The disclosure provides methods of managing opioid therapy, particularly, for pain management. The methods comprise determining in a subject, for example, a subject who has received an opioid treatment, pupillary unrest in ambient light (PUAL). Low values of PUAL can be used to identify patients at risk for opioid side-effects, such as opioid-related respiratory depression (OIRD), and who warrant attention to prevent such side effects. Accordingly, the methods include monitoring the patients having low values of PUAL for signs of adverse side-effects and/or limiting or avoiding administration of opioids.

Improved optical coherence tomography systems and methods to measure thickness of the retina are presented. The systems may be compact, handheld, provide in-home monitoring, allow the patient to measure himself or herself, and be robust enough to be dropped while still measuring the retina reliably.

Embodiments of a compact portable nuclear magnetic resonance (NMR) device are described which generally include a housing that provides a magnetic shield; an axisymmetric permanent magnet assembly in the housing and having a bore, a plurality of magnetic elements that together provide a well confined axisymmetric magnetization for generating a near-homogenous magnetic dipole field B.sub.0 directed along a longitudinal axis and providing a sample cavity for receiving a sample, and high magnetic permeability soft steel poles to improve field uniformity: a shimming assembly with coils disposed at the longitudinal axis for spatially correcting the near homogenous magnetic field B.sub.0; and a spectrometer having a control unit for measuring a metabolite in the sample by applying magnetic stimulus pulses to the sample, measuring free induction delay signals generated by an ensemble of hydrogen protons within the sample; and suppressing a water signal by using a dephasing gradient with frequency selective suppression.

According to some aspects, a system configured to facilitate imaging an infant using a magnetic resonance imaging (MRI) device is provided herein. The system comprises an infant-carrying apparatus comprising an infant support configured to support the infant and an isolette for positioning the infant relative to the MRI device, the isolette comprising: a base for supporting the infant-carrying apparatus; and a bottom surface configured to be coupled to the MRI device. In some embodiments, the infant-carrying apparatus further comprises at least one radio frequency (RF) coil coupled to the infant support and configured to be coupled to the MRI device to detect MR signals during imaging performed by the MRI device. A method for positioning an infant relative to an MRI device using an infant-carrying apparatus and isolette is further provided herein.

The present disclosure relates to compounds that are useful as near-infrared fluorescence probes, wherein the compounds include i) a ligand that binds to the active site of carbonic anhydrase, ii) a dye molecule, and iii) a linker molecule that comprises an amino acid, amide, ureido, or polyethylene glycol derivative thereof. The disclosure further describes methods and compositions for making and using the compounds, methods incorporating the compounds, and kits incorporating the compounds.

A portable apparatus for determining refractive error in the human eye comprises an elongate base rail having a left side base rail portion and a right side base rail portion; a first lens carrier housing mounted on the left side base rail portion, a first lens carrier carrying a plurality of corrective lenses and being substantially housed within the first lens carrier housing so as to expose a corrective lens of the first lens carrier in a test position of the first lens carrier housing; a second lens carrier housing mounted on the right side base rail portion, a second lens carrier carrying a plurality of corrective lenses and being substantially housed within the second lens carrier housing so as to expose a corrective lens of the second lens carrier in a test position of the second lens carrier housing; a first user operable control adapted for moving the first lens carrier relative to the first lens carrier housing and a second user operable control adapted to move the second lens carrier relative to the second lens carrier housing, whereby the first user operable control and the second user operable control are each movable to select a corrective lens to be exposed in the test position of the respective carrier housing. and wherein the portable apparatus includes at least one of (a) the base rail is adapted to be foldable at a middle portion thereof and (b) one of the first lens carrier housing and the second lens carrier housing is detachable from the respective left side base rail portion or right side base rail portion.

A system and method is provided for monitoring a biological substance in a bodily orifice. The system includes a wearable device configured to be worn in a bodily orifice. A biosensor is carried by the wearable device and is constructed and arranged to obtain raw data regarding a biological substance in the orifice. The biosensor includes a processor circuit to provide processed data from the raw data, and a transmitter to wirelessly transmit the processed data to a second device.

The present invention relates to a deep learning-based multiple skin lesion detection system, a multiple lesion detection method, and a computer-readable recording medium that has a program for implementing same recorded thereon. The system according to the present invention enables accurate classification and detection of various skin lesions having similar characteristics, on the basis of a context-dependent decision-making structure in which the local spatial correlation between various skin lesions in skin is considered.

An oximetry device sealed in a sheath directs a user to allow the oximetry device to make oximetry readings at a number of different tissue locations of a patient and average two or more of the oximetry readings by directing the lifts and placements of the oximetry device and sheath to and from the different tissue locations and detecting the lift and placements. The averages are generated and displayed on a display of the device for the oximetry readings if the lifts are made while use directions for the lifts are displayed on a display of the oximetry device. The averages are not generated if the lifts are not made while the user directions for the lifts are not displayed. The averages are simultaneously displayed with the oximetry readings which are instantaneous measurement for patient tissue.

A method of identifying and locating tissue abnormalities in a biological tissue includes irradiating an electromagnetic signal, via a probe defining a transmitting probe, in the vicinity of a biological tissue. The irradiated electromagnetic signal is received at a probe, defining a receiving probe, after the signal is scattered/reflected by the biological tissue. Blood flow information pertaining to the biological tissue is provided. Based on the received irradiated electromagnetic signal and the blood flow information, tissue properties of the biological tissue are reconstructed. A tracking unit determines the position of at least one of the transmitting probe and the receiving probe while the step of receiving is being carried out, the at least one probe defining a tracked probe. The reconstructed tissue properties are correlated with the determined probe position so that tissue abnormalities can be identified and spatially located.